UNAIDS: Investing in local production of medicines is a priority
Expanding access to HIV treatment has profound benefits, not only for individual recipients and their families but for economies as a whole, given the increased productivity, greater longevity and lower long-term health expenditure.15 Oct 2014
If the ambitious but realistic global goal of ending the AIDS epidemic by 2030 is to become a reality, HIV prevention, testing, treatment and counselling services must be scaled up rapidly. A crucial element of this is ensuring sustainable supplies of high-quality medicines in the most affected countries.
A high-level meeting held in Geneva, Switzerland, on 14 October explored how countries can improve access to medicines and develop their domestic production, with the help of public and private investment.Share this on: